Synthesis of a beta-amino acid pharmacophore via a beta-lactam intermediate. 2005

Rémy Angelaud, and Yong-Li Zhong, and Peter Maligres, and Jaemoon Lee, and David Askin
Merck Process Research, Merck Research Laboratories, P.O. Box 2000, Rahway, New Jersey 07065, USA. remy_angelaud@merck.com

A stereoselective synthesis of (R)-beta-amino acid 1 via a beta-lactam intermediate is discussed.

UI MeSH Term Description Entries
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D000215 Acylation The addition of an organic acid radical into a molecule.
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D047090 beta-Lactams Four-membered cyclic AMIDES, best known for the PENICILLINS based on a bicyclo-thiazolidine, as well as the CEPHALOSPORINS based on a bicyclo-thiazine, and including monocyclic MONOBACTAMS. The BETA-LACTAMASES hydrolyze the beta lactam ring, accounting for BETA-LACTAM RESISTANCE of infective bacteria. beta-Lactam,4-Thia-1-Azabicyclo(3.2.0)Heptanes,4-Thia-1-Azabicyclo(4.2.0)Octanes,beta Lactam,beta Lactams

Related Publications

Rémy Angelaud, and Yong-Li Zhong, and Peter Maligres, and Jaemoon Lee, and David Askin
December 2000, The Journal of organic chemistry,
Rémy Angelaud, and Yong-Li Zhong, and Peter Maligres, and Jaemoon Lee, and David Askin
March 1977, Journal of the American Chemical Society,
Rémy Angelaud, and Yong-Li Zhong, and Peter Maligres, and Jaemoon Lee, and David Askin
March 2008, Bioorganic & medicinal chemistry letters,
Rémy Angelaud, and Yong-Li Zhong, and Peter Maligres, and Jaemoon Lee, and David Askin
May 1975, The Journal of organic chemistry,
Rémy Angelaud, and Yong-Li Zhong, and Peter Maligres, and Jaemoon Lee, and David Askin
November 2002, Journal of biotechnology,
Rémy Angelaud, and Yong-Li Zhong, and Peter Maligres, and Jaemoon Lee, and David Askin
February 1995, Journal of bacteriology,
Rémy Angelaud, and Yong-Li Zhong, and Peter Maligres, and Jaemoon Lee, and David Askin
November 1987, Plant physiology,
Rémy Angelaud, and Yong-Li Zhong, and Peter Maligres, and Jaemoon Lee, and David Askin
December 2003, The Journal of organic chemistry,
Rémy Angelaud, and Yong-Li Zhong, and Peter Maligres, and Jaemoon Lee, and David Askin
November 2002, Organic letters,
Rémy Angelaud, and Yong-Li Zhong, and Peter Maligres, and Jaemoon Lee, and David Askin
February 2010, Molecular diversity,
Copied contents to your clipboard!